[go: up one dir, main page]

GB202007441D0 - Polypeptide - Google Patents

Polypeptide

Info

Publication number
GB202007441D0
GB202007441D0 GBGB2007441.5A GB202007441A GB202007441D0 GB 202007441 D0 GB202007441 D0 GB 202007441D0 GB 202007441 A GB202007441 A GB 202007441A GB 202007441 D0 GB202007441 D0 GB 202007441D0
Authority
GB
United Kingdom
Prior art keywords
polypeptide
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Ceased
Application number
GBGB2007441.5A
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Autolus Ltd
Original Assignee
Autolus Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Autolus Ltd filed Critical Autolus Ltd
Priority to GBGB2007441.5A priority Critical patent/GB202007441D0/en
Publication of GB202007441D0 publication Critical patent/GB202007441D0/en
Priority to PCT/GB2021/051209 priority patent/WO2021234383A1/en
Ceased legal-status Critical Current

Links

GBGB2007441.5A 2020-05-19 2020-05-19 Polypeptide Ceased GB202007441D0 (en)

Priority Applications (2)

Application Number Priority Date Filing Date Title
GBGB2007441.5A GB202007441D0 (en) 2020-05-19 2020-05-19 Polypeptide
PCT/GB2021/051209 WO2021234383A1 (en) 2020-05-19 2021-05-19 Single domain antibodies against hace2 and their use to prevent sars-cov-2 infection

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GBGB2007441.5A GB202007441D0 (en) 2020-05-19 2020-05-19 Polypeptide

Publications (1)

Publication Number Publication Date
GB202007441D0 true GB202007441D0 (en) 2020-07-01

Family

ID=71135259

Family Applications (1)

Application Number Title Priority Date Filing Date
GBGB2007441.5A Ceased GB202007441D0 (en) 2020-05-19 2020-05-19 Polypeptide

Country Status (2)

Country Link
GB (1) GB202007441D0 (en)
WO (1) WO2021234383A1 (en)

Cited By (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN113698487A (en) * 2021-08-16 2021-11-26 中国科学院微生物研究所 Anti-human ACE2 monoclonal antibody and application thereof
CN114989264A (en) * 2021-03-01 2022-09-02 中国医学科学院基础医学研究所 Polypeptide composition specifically binding to SARS-CoV-2 spike protein, preparation method and application thereof

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2021211406A1 (en) * 2020-04-13 2021-10-21 Maddon Advisors Llc Tmprss2-targeted compositions and methods for treating covid-19
CN116808200A (en) * 2022-03-21 2023-09-29 中国科学院微生物研究所 Construct of nanobody S43 and application thereof
EP4532563A2 (en) * 2022-06-03 2025-04-09 The Rockefeller University Coronavirus-inhibiting antibodies
WO2025056771A1 (en) * 2023-09-15 2025-03-20 Institut Pasteur Antibodies directed to ace2 and their use as medicine

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU515751B2 (en) 1977-09-23 1981-04-30 Bryant Manufacturing Pty. Ltd. Plug and socket connector for electric circuits
US9321832B2 (en) 2002-06-28 2016-04-26 Domantis Limited Ligand
EP1600459A3 (en) 2002-06-28 2005-12-07 Domantis Limited Ligand
JP2008500830A (en) 2004-06-01 2008-01-17 ドマンティス リミテッド Bispecific fusion antibodies with increased serum half-life
EP1877073B1 (en) 2004-12-01 2013-09-25 The Secretary of State for Health Non-cytotoxic protein conjugates
JP5677972B2 (en) 2008-11-18 2015-02-25 メリマック ファーマシューティカルズ インコーポレーティッド Human serum albumin linker and its conjugates
BR112012001681A2 (en) 2009-07-16 2019-09-24 Graxo Group Ltd improved serum anti-albumin binding domains
US11384141B2 (en) * 2018-04-24 2022-07-12 National Research Council Of Canada Serum albumin binding antibodies for tuneable half-life extension of biologics

Cited By (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN114989264A (en) * 2021-03-01 2022-09-02 中国医学科学院基础医学研究所 Polypeptide composition specifically binding to SARS-CoV-2 spike protein, preparation method and application thereof
CN114989264B (en) * 2021-03-01 2023-07-21 中国医学科学院基础医学研究所 Polypeptide composition specifically binding to SARS-CoV-2 spike protein and its preparation method and application
CN113698487A (en) * 2021-08-16 2021-11-26 中国科学院微生物研究所 Anti-human ACE2 monoclonal antibody and application thereof

Also Published As

Publication number Publication date
WO2021234383A1 (en) 2021-11-25

Similar Documents

Publication Publication Date Title
IL289122A (en) Polypeptides
GB202017649D0 (en) Polypeptide
GB202007441D0 (en) Polypeptide
IL289119A (en) Polypeptides
IL288419A (en) Recombinant herpesvirales vector
IL299811A (en) Polypeptide
IL288412A (en) Peptides
IL312556A (en) Novel peptides
GB202007532D0 (en) Polypeptides
GB201810052D0 (en) Polypeptide
GB202019879D0 (en) Polypeptide
IL308465A (en) Sars-cov-2 polypeptides
GB202117405D0 (en) Peptide
IL290019B2 (en) Melanocyte-regulating peptides
GB202019908D0 (en) Cripr polypeptides
GB201918693D0 (en) Peptide
GB202119034D0 (en) Polypeptide
GB202105924D0 (en) Polypeptide
GB202103001D0 (en) Polypeptide
GB202100648D0 (en) Polypeptide
GB202013372D0 (en) Polypeptide
GB202011813D0 (en) Polypeptide
GB202005333D0 (en) Polypeptide
GB202319601D0 (en) Polypeptide
GB202102598D0 (en) An isolated polypeptide

Legal Events

Date Code Title Description
AT Applications terminated before publication under section 16(1)